


Neuroendocrine Cancer – normally slow but don’t be fooled!

Phase 3 CABINET Clinical Trial – Cabozantinib for Advanced Neuroendocrine Tumours

Belzutifan for the Treatment of Advanced Pheochromocytoma/Paraganglioma (PPGL), Pancreatic Neuroendocrine Tumor (pNET), or Von Hippel-Lindau (VHL) Disease-Associated Tumors

Neuroendocrine Neoplasms (NEN) – genetic related syndromes

The Hidden Pheochromocytoma

Neuroendocrine Cancer: Glossary of Terms

Every picture tells a story (point, click, read)

Neuroendocrine Cancer – no sweat!

Targeted Therapy for Neuroendocrine Cancer – Sunitinib (Sutent)

Clinical Trial: Lu-177 DOTATOC (PRRT) in adult subjects with Somatostatin receptor (SSTR) positive Pulmonary, Pheochromocytoma, Paraganglioma, Unknown primary, and Thymic Neuroendocrine Tumors

Featuring Kirsty Dalglish – Pheochromocytoma and Pregnancy

“Please find something wrong with me”

Clinical Trials – PEN-221 for Neuroendocrine Cancer

Clinical Trials – ONC201 for Neuroendocrine Cancer (including Pheo/Para)

Neuroendocrine Cancer Hormonal Syndromes – a witch’s brew

NETwork with Ronny © – Community Newsletter NOVEMBER 2017

Living with Neuroendocrine Cancer – the 7 Year Itch

Weight – the NET Effect

Genetics and Neuroendocrine Tumors

Ever wonder what caused your Neuroendocrine Cancer?

The Invisible NET Patient Population

NETwork with Ronny © – Community Newsletter JUNE 2017

Immunotherapy: Studies with Neuroendocrine Neoplasms

All you need to know about Peptide Receptor Radionuclide Therapy (PRRT)

Theranostics for Neuroendocrine Cancer – A Find and Destroy Mission
NETwork with Ronny © – Newsletter December 2016

Neuroendocrine Tumours: a spotlight on Pheochromocytoma and Paraganglioma

Neuroendocrine – don’t let it be a Crisis

Neuroendocrine Tumours (NET) – benign vs malignant

Neuroendocrine Cancer – If you can see it, you can detect it!

Neuroendocrine Cancer – tumour markers and hormone levels

The 5 E’s (of Carcinoid Syndrome)

A spotlight on Multiple Endocrine Neoplasia (MEN)

I bet my flush beats yours?
PRRT and the NHS England Cancer Drugs Fund (now archived information)

The Syndromes of Neuroendocrine Cancer – Early Signs of a Late Diagnosis

Carcinoid vs Neuroendocrine

Neuroendocrine Cancer – Horrible Hormones
